Print

Protox Therapeutics Inc. (PRX.V) Reports 2009 Third Quarter Results  
11/16/2009 12:09:36 PM

VANCOUVER, Nov. 16 /CNW/ - Protox Therapeutics Inc. (TSX: PRX), a leader in the development of receptor targeted fusion proteins, today announced financial results for the third quarter, ended September 30, 2009.
//-->